NCT03015818View on ClinicalTrials.gov

Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD)

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 30, 2017

Primary Completion Date

May 3, 2019

Study Completion Date

May 3, 2019

Conditions
Aortic Bioprosthesis Structural Valve Dysfunction
Interventions
OTHER

18F-Fluoride PET-CT ; CT calcium scoring ; 18F-FDG PET-CT

18F-Fluoride PET-CT CT calcium scoring 18F-FDG PET-CT

Trial Locations (1)

Unknown

Nantes University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03015818 - Assessment of Osteoblastic Activity With 18F-Fluoride in Aortic Bioprosthesis Structural Valve Dysfunction (SVD) | Biotech Hunter | Biotech Hunter